Back to News
Market Impact: 0.15
Caspian Therapeutics Appoints Manasi Jaiman, M.D., M.P.H., and Elizabeth Mily to Board of Directors
Source: GlobeNewswire
Healthcare & BiotechManagement & GovernanceCompany Fundamentals
Caspian announced board additions bringing diabetes-development and company-building expertise as it prepares KO-7246 for advancement into clinical testing. The appointments may strengthen clinical-development oversight and corporate execution, but no financial terms, trial timeline, or efficacy data were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
CASP0.45
More News
- Can Trump Oust Powell From the Fed Board? What to Know
- $8.2B acquisition validates AI-picked chip stock: +20% since June
- Nike Warns Sales Slump Will Worsen This Fiscal Year
- Nuveen CEO on Schroders Deal, Plans for Combined Company
- Broadcom to lend Anthropic up to $42 billion to lease its chips, filing says
- New Mexico wants Meta to pay up to $40 billion in penalties after data privacy trial